GSK (NYSE:GSK) announced that momelotinib, its approved Janus kinase (JAK) inhibitor, has received Orphan Drug Designation from both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of VEXAS syndrome.
Oil prices fell more than 2% on Friday, extending a downswing from the previous session after U.S. President Donald Trump canceled plans for targeted military strikes against Iran.
The Bank Policy Institute and The Clearing House have urged US regulators to expand anti-money laundering oversight of stablecoins beyond issuers and focus more closely on activity in secondary markets.
Chainlink remained resilient after the US government transferred 98,590 LINK tokens worth about $768,000 to Coinbase Prime from wallets associated with seized FTX Alameda assets, raising concerns about potential selling pressure.
Microba Life Sciences (ASX:MAP) secured commitments to raise $5 million through a two-tranche share placement.
Citigroup is launching a blockchain-based marketplace for private company shares, giving institutional and wealthy investors a new way to gain exposure to pre-IPO firms through tokenised assets.
Osmond Resources (ASX:OSM) announced strides in the development of its flagship Orión EU Critical Minerals Project.
Cardano is approaching a key regulatory milestone that could strengthen its case for a US spot exchange-traded fund as the cryptocurrency nears the SEC's six-month futures-market requirement.
Vita Life Sciences (ASX:VLS) announced its financial guidance for the half-year ending June 30.
A White House meeting involving administration officials, lawmakers and law enforcement organisations has highlighted a potential path forward for the CLARITY Act as supporters seek a Senate vote before the August recess.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas
